4//SEC Filing
Griffith Barry K 4
Accession 0001140361-11-004494
CIK 0000799694other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 7:16 AM ET
Size
21.8 KB
Accession
0001140361-11-004494
Insider Transaction Report
Form 4
Griffith Barry K
Director
Transactions
- Award
Stock Options (Common Stock)
2011-01-26$0.03/sh+100,000$3,000→ 100,000 totalExercise: $0.03From: 2011-01-07Exp: 2018-01-07→ Common Stock (100,000 underlying) - Disposition to Issuer
Stock Options (Common Stock)
2011-01-26$0.23/sh−20,000$4,600→ 480,000 totalExercise: $0.23From: 2007-12-15Exp: 2014-12-15→ Common Stock (20,000 underlying) - Disposition to Issuer
Stock Options (Common Stock)
2011-01-26$0.40/sh−300,000$120,000→ 120,000 totalExercise: $0.40From: 2007-03-22Exp: 2013-03-22→ Common Stock (300,000 underlying) - Disposition to Issuer
Stock Ortions (Common Stock)
2011-01-26$0.45/sh−10,000$4,500→ 110,000 totalExercise: $0.45From: 2007-03-22Exp: 2013-03-22→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Options (Common Stock)
2011-01-26$0.24/sh−10,000$2,400→ 0 totalExercise: $0.24From: 2008-12-19Exp: 2017-12-19→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Options (Common Stock)
2011-01-26$0.23/sh−50,000$11,500→ 430,000 totalExercise: $0.23From: 2006-12-15Exp: 2014-12-15→ Common Stock (50,000 underlying) - Disposition to Issuer
Stock Options (Common Stock)
2011-01-26$0.24/sh−10,000$2,400→ 420,000 totalExercise: $0.24From: 2006-12-05Exp: 2015-12-05→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Options (Common Stock)
2011-01-26$0.40/sh−100,000$40,000→ 10,000 totalExercise: $0.40From: 2008-07-06Exp: 2013-07-06→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]On January 7, 2001, the Board of Directors of the Issuer determined that it would be in the best interest of the Company and its shareholders to reduce the number of authorized but unissued shares of common stock to outstanding stock purchase rights. If successfully accomplished, such reduction would serve to increase the number of shares available for the sale to finance the continuing operations of the Company. Accordingly, the board of Directors specifically authorized the exchange of presently outstanding rights to purchase 1,475,000 shares at prices between $0.165 and $1.33 for the rights to purchase up to 295,000 shares at a price of $0.03 per share. The transaction being reported on hereby reflects the acceptance by the filer of such exchange. The exchange was made on January 26, 2011.
- [F2]Mr. Griffith hold a direct interest in 1,800 Units and a direct interest in 100,000 stock options to purchase common stock.
Documents
Issuer
Oncologix Tech Inc.
CIK 0000799694
Entity typeother
Related Parties
1- filerCIK 0001312679
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 7:16 AM ET
- Size
- 21.8 KB